HERC4 synergizes with USP16 to promote lung adenocarcinoma growth by augmenting protein translation via stabilizing

Qiuyun Jiang1, Yiyang Liu2, Wenshuang Sun1

  • 1The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University & Guangdong Provincial Key Laboratory of Protein Modification and Diseases, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.

Oncogene
|July 29, 2026
PubMed

Insights

HERC4 and USP16 stabilize RPS15, a ribosomal protein, promoting lung adenocarcinoma growth by enhancing protein translation. This HERC4/USP16-RPS15 pathway offers a potential therapeutic target for LUAD.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Ubiquitination Pathways

Background:

  • HERC4, a ubiquitin ligase, has known roles in various cancers.
  • Its specific function in lung adenocarcinoma (LUAD) remained unclear.
  • Understanding HERC4's role is crucial for LUAD treatment strategies.

Purpose of the Study:

  • To elucidate the role and mechanism of HERC4 in lung adenocarcinoma.
  • To investigate the interaction between HERC4, USP16, and RPS15 in LUAD.
  • To explore the HERC4/USP16-RPS15 axis as a potential therapeutic target.

Main Methods:

  • Analysis of HERC4 dysregulation in LUAD tissues.
  • Co-immunoprecipitation to study protein interactions (HERC4, USP16, RPS15).
  • Western blotting to assess ubiquitination levels and protein stability.
  • RNA interference (siRNA) to knock down HERC4 and USP16.
  • Cell proliferation assays and ribosome-bound protein analysis.

Main Results:

  • HERC4 is upregulated in LUAD and promotes cell growth.
  • HERC4 stabilizes RPS15 by deubiquitination, independent of its E3 ligase activity.
  • HERC4 collaborates with USP16 to prevent RPS15 K48-linked ubiquitination.
  • Knockdown of HERC4/USP16 reduces protein translation and increases p53, decreases p38.
  • RPS15 overexpression partially rescues these effects.

Conclusions:

  • HERC4 and USP16 synergize to deubiquitinate and stabilize RPS15.
  • This axis enhances global protein translation and promotes LUAD cell proliferation.
  • The HERC4/USP16-RPS15 pathway is a promising therapeutic target for LUAD.

Related Concept Videos

Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...